Shots: The Japan Ministry of Health, Labor and Welfare approves the evaluation of iPS cells in a clinical research for spinal cord injuries at Keio University in Tokyo, with expected onset in H1’2019 The study is will be conducted enrolling 4 adults with spinal cord injuries whose sensation and bodily mobility have been completely lost, […]Read More
Tags : iPSCs
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US